I
507.05
10.69 (2.15%)
| Previous Close | 496.36 |
| Open | 488.60 |
| Volume | 1,405,075 |
| Avg. Volume (3M) | 2,072,506 |
| Market Cap | 181,663,334,400 |
| Price / Earnings (TTM) | 78.73 |
| Price / Earnings (Forward) | 67.11 |
| Price / Sales | 21.76 |
| Price / Book | 10.95 |
| 52 Weeks Range | |
| Earnings Date | 22 Apr 2025 |
| Profit Margin | 27.81% |
| Operating Margin (TTM) | 31.33% |
| Diluted EPS (TTM) | 6.42 |
| Quarterly Revenue Growth (YOY) | 25.20% |
| Quarterly Earnings Growth (YOY) | 13.10% |
| Total Debt/Equity (MRQ) | 0.88% |
| Current Ratio (MRQ) | 4.07 |
| Operating Cash Flow (TTM) | 2.42 B |
| Levered Free Cash Flow (TTM) | 1.20 B |
| Return on Assets (TTM) | 8.67% |
| Return on Equity (TTM) | 15.62% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | Intuitive Surgical, Inc. | Bearish | Bullish |
AIStockmoo Score
-0.6
| Analyst Consensus | -0.5 |
| Insider Activity | -3.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -3.5 |
| Average | -0.60 |
|
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Large Growth |
| % Held by Insiders | 0.52% |
| % Held by Institutions | 89.41% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 650.00 (Citigroup, 28.19%) | Buy |
| Median | 582.50 (14.88%) | |
| Low | 440.00 (Deutsche Bank, -13.22%) | Sell |
| Average | 567.50 (11.92%) | |
| Total | 6 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 502.08 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Deutsche Bank | 09 Jun 2025 | 440.00 (-13.22%) | Sell | 526.15 |
| Citigroup | 22 May 2025 | 650.00 (28.19%) | Buy | 542.67 |
| Barclays | 24 Apr 2025 | 635.00 (25.23%) | Buy | 508.13 |
| Baird | 23 Apr 2025 | 575.00 (13.40%) | Buy | 487.93 |
| 18 Mar 2025 | 600.00 (18.33%) | Buy | 483.95 | |
| Evercore ISI Group | 23 Apr 2025 | 470.00 (-7.31%) | Hold | 487.93 |
| Piper Sandler | 23 Apr 2025 | 575.00 (13.40%) | Buy | 487.93 |
| RBC Capital | 23 Apr 2025 | 605.00 (19.32%) | Buy | 487.93 |
| Truist Securities | 23 Apr 2025 | 590.00 (16.36%) | Buy | 487.93 |
| 17 Mar 2025 | 605.00 (19.32%) | Buy | 488.80 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BROSIUS MARK | - | 555.65 | -1,076 | -597,877 |
| ROSA DAVID J. | - | 543.78 | -1,525 | -831,766 |
| Aggregate Net Quantity | -2,601 | |||
| Aggregate Net Value ($) | -1,429,642 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 552.25 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ROSA DAVID J. | Officer | 10 Jun 2025 | Disposed (-) | 674 | 529.60 | 356,950 |
| ROSA DAVID J. | Officer | 10 Jun 2025 | Option execute | 1,358 | - | - |
| BROSIUS MARK | Officer | 06 Jun 2025 | Automatic sell (-) | 216 | 557.08 | 120,329 |
| BROSIUS MARK | Officer | 05 Jun 2025 | Automatic sell (-) | 215 | 558.06 | 119,983 |
| BROSIUS MARK | Officer | 04 Jun 2025 | Automatic sell (-) | 215 | 557.95 | 119,959 |
| ROSA DAVID J. | Officer | 04 Jun 2025 | Disposed (-) | 851 | 557.95 | 474,815 |
| BROSIUS MARK | Officer | 03 Jun 2025 | Automatic sell (-) | 215 | 551.85 | 118,648 |
| BROSIUS MARK | Officer | 02 Jun 2025 | Automatic sell (-) | 215 | 553.29 | 118,957 |
| Date | Type | Details |
|---|---|---|
| 15 May 2025 | Announcement | Intuitive Announces CEO Transition Effective July 1, 2025 |
| 01 May 2025 | Announcement | Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection |
| 22 Apr 2025 | Announcement | Intuitive Announces First Quarter Earnings |
| 17 Apr 2025 | Announcement | New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery |
| 10 Apr 2025 | Announcement | U.S. FDA clears first stapler designed for single-port robotic surgery |
| 10 Apr 2025 | Announcement | AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge |
| 27 Mar 2025 | Announcement | Peer-Reviewed Studies on Intuitive’s Force Feedback Technology Demonstrate its Potential to Reduce Force on Tissue and Enhance Surgeon Performance |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |